Compare TLK & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLK | LH |
|---|---|---|
| Founded | 1884 | 1971 |
| Country | Indonesia | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.8B | 21.2B |
| IPO Year | 1995 | N/A |
| Metric | TLK | LH |
|---|---|---|
| Price | $21.25 | $254.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $301.33 |
| AVG Volume (30 Days) | 396.8K | ★ 660.3K |
| Earning Date | 10-30-2025 | 02-05-2026 |
| Dividend Yield | ★ 4.96% | 1.13% |
| EPS Growth | N/A | ★ 98.36 |
| EPS | 0.01 | ★ 10.19 |
| Revenue | $8,829,079,245.00 | ★ $13,765,300,000.00 |
| Revenue This Year | $0.71 | $10.82 |
| Revenue Next Year | $3.04 | $4.44 |
| P/E Ratio | ★ $15.69 | $24.98 |
| Revenue Growth | N/A | ★ 8.28 |
| 52 Week Low | $13.15 | $209.38 |
| 52 Week High | $22.39 | $293.72 |
| Indicator | TLK | LH |
|---|---|---|
| Relative Strength Index (RSI) | 51.42 | 41.22 |
| Support Level | $20.52 | $250.90 |
| Resistance Level | $20.94 | $255.42 |
| Average True Range (ATR) | 0.25 | 4.33 |
| MACD | -0.10 | -0.55 |
| Stochastic Oscillator | 50.34 | 21.74 |
PT Telkom Indonesia (Persero) Tbk is the integrated telecommunications provider in Indonesia. The company is focusing on dividing business into 3 Digital Business Domains namely, digital connectivity, digital platform, and digital services. It also provides a wide range of other communication services, including telephone network, interconnection services, multimedia, data and internet communication-related services, satellite transponder leasing, leased line, intelligent network and related services, cable television, and VoIP services. The group derives revenue from product lines: Mobile, Consumer, Enterprise, WIB and Others.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.